Danielvettori4421 Jan, 2025Business
Medtech innovation often faces a paradox: balancing the need for groundbreaking technologies with the constraints of efficiency and profitability. This challenge was the focal point of Duke Rohlen’s keynote, The Middle Path to Innovation, presented at LSI Europe ’25. Drawing from his thesis published in the Harvard Business Review, Rohlen, the Founder, CEO, and Chairman of Ajax Health, introduced the growth driver framework—a strategy for developing high-growth medtech products within slow-growth companies. Alongside Mano Iyer of Sofinnova Partners, Rohlen outlined a transformative approach for medtech entrepreneurs and investors navigating an increasingly complex landscape.
Sc88
Abc999
Songmaker Ai
11aa
555win
59z
Barr Richard
Hart Kjeldsen
Walker Hines
Hemmingsen Fisher